{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:29:36Z","timestamp":1772119776444,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370206, 82170198"],"award-info":[{"award-number":["82370206, 82170198"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10749-z","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:25:54Z","timestamp":1751369154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CALR regulates the proliferation and drug sensitivity of multiple myeloma cells through the BCL2 signaling pathway"],"prefix":"10.1007","volume":"52","author":[{"given":"Yin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqi","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoteng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"10749_CR1","doi-asserted-by":"crossref","unstructured":"Florent M, Paola N, Nizar JB et al (2024) Multiple myeloma. Nat Rev Dis Primers 10(1)","DOI":"10.1038\/s41572-024-00535-9"},{"key":"10749_CR2","doi-asserted-by":"crossref","unstructured":"Vincent S (2024) R. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol 99(9)","DOI":"10.1002\/ajh.27422"},{"key":"10749_CR3","doi-asserted-by":"crossref","unstructured":"David MCDS, Rosa T, Luca B et al (2024) New horizons in our Understanding of precursor multiple myeloma and early interception. Nat Rev Cancer 24(12)","DOI":"10.1038\/s41568-024-00755-x"},{"key":"10749_CR4","first-page":"0","volume":"376","author":"P Ashruti","year":"2024","unstructured":"Ashruti P, Aayushi L, Sarah AH et al (2024) Recent advances in targeted drug delivery systems for multiple myeloma. J Control Release 376:0","journal-title":"J Control Release"},{"key":"10749_CR5","doi-asserted-by":"crossref","unstructured":"Okura GC, Bharadwaj AG, Waisman DM (2025) Calreticulin\u2014From the Endoplasmic reticulum to the plasma Membrane\u2014Adventures of a wandering protein. Cancers 17(2)","DOI":"10.3390\/cancers17020288"},{"key":"10749_CR6","doi-asserted-by":"crossref","unstructured":"Michalak M, Calreticulin (2023) Endoplasmic reticulum Ca2\u2009+\u2009gatekeeper. J Cell Mol Med 28(5)","DOI":"10.1111\/jcmm.17839"},{"key":"10749_CR7","doi-asserted-by":"crossref","unstructured":"Okura GC, Bharadwaj AG, Waisman DM (2024) Calreticulin\u2014Enigmatic Discovery. Biomolecules 14(7)","DOI":"10.3390\/biom14070866"},{"issue":"02","key":"10749_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4149\/neo_2024_240116N24","volume":"71","author":"L Liang","year":"2024","unstructured":"Liang L, Wang J, Guo T et al (2024) Calreticulin regulates the expression of MMP14 and ADAR1 through EIF2AK2 signaling to promote the proliferation and progression of malignant melanoma cells. Neoplasma 71(02):180\u2013192","journal-title":"Neoplasma"},{"key":"10749_CR9","doi-asserted-by":"crossref","unstructured":"Turdo A, Gaggianesi M, D\u2019Accardo C et al (2023) EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas. Front Immunol 14","DOI":"10.3389\/fimmu.2023.1266265"},{"key":"10749_CR10","doi-asserted-by":"crossref","unstructured":"He B, Li Y, Liu X et al (2021) Bioinformatics analysis for the role of CALR in human cancers. PLoS ONE 16(12)","DOI":"10.1371\/journal.pone.0261254"},{"issue":"3","key":"10749_CR11","doi-asserted-by":"publisher","first-page":"6856","DOI":"10.1080\/21655979.2022.2040874","volume":"13","author":"F Gao","year":"2022","unstructured":"Gao F, Mu X, Wu H et al (2022) Calreticulin (CALR)-induced activation of NF-\u0138B signaling pathway boosts lung cancer cell proliferation. Bioengineered 13(3):6856\u20136865","journal-title":"Bioengineered"},{"key":"10749_CR12","doi-asserted-by":"crossref","unstructured":"Xie S, Jiang X, Qin R et al (2021) miR-1307 promotes hepatocarcinogenesis by CALR-OSTC-endoplasmic reticulum protein folding pathway. iScience 24(11)","DOI":"10.1016\/j.isci.2021.103271"},{"key":"10749_CR13","doi-asserted-by":"crossref","unstructured":"Gao S, Wang X, Huang Y et al (2024) Calreticulin-driven autophagy enhances cell proliferation in laryngeal squamous cell carcinoma. Tissue Cell 91","DOI":"10.1016\/j.tice.2024.102603"},{"key":"10749_CR14","doi-asserted-by":"crossref","unstructured":"Wei N, Sun D, Li C et al (2022) MicroRNA-206 suppresses growth and metastasis of breast cancer stem cells via blocking EVI-1-mediated CALR expression. PLoS ONE 17(9)","DOI":"10.1371\/journal.pone.0274919"},{"key":"10749_CR15","doi-asserted-by":"crossref","unstructured":"Wang L, Chen J, Zuo Q et al (2022) Calreticulin enhances gastric cancer metastasis by dimethylating H3K9 in the E-cadherin promoter region mediating by G9a. Oncogenesis 11(1)","DOI":"10.1038\/s41389-022-00405-7"},{"key":"10749_CR16","doi-asserted-by":"crossref","unstructured":"Chen C-C, Hsu L-W, Chen K-D et al (2025) Extracellular calreticulin regulates fibrogenic and Immunogenic properties of hepatic stellate cells. Int Immunopharmacol 148","DOI":"10.1016\/j.intimp.2025.114129"},{"issue":"6","key":"10749_CR17","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.ccell.2023.04.015","volume":"41","author":"E Guilbaud","year":"2023","unstructured":"Guilbaud E, Kroemer G, Galluzzi L (2023) Calreticulin exposure orchestrates innate immunosurveillance. Cancer Cell 41(6):1014\u20131016","journal-title":"Cancer Cell"},{"key":"10749_CR18","doi-asserted-by":"crossref","unstructured":"Mei K-C, Thota N, Wei P-S et al (2024) Calreticulin P-domain-derived Eat-me peptides for enhancing liposomal uptake in dendritic cells. Int J Pharm 653","DOI":"10.1016\/j.ijpharm.2024.123844"},{"key":"10749_CR19","doi-asserted-by":"crossref","unstructured":"Castellanos JP, Genereux JC (2023) Calreticulin surface presentation: a signal for natural killer cells to attack. Signal Transduct Target Therapy 8(1)","DOI":"10.1038\/s41392-023-01551-z"},{"key":"10749_CR20","unstructured":"Valentina B, Barbara M, Alessandra I et al (2025) CALR-mutated myeloproliferative neoplasms. Leuk Lymphoma. (0)"},{"key":"10749_CR21","doi-asserted-by":"crossref","unstructured":"Del Serrano A, Beltr\u00e1n-Visiedo M, de Poo-Rodr\u00edguez V et al (2022) Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis. OncoImmunology 11(1)","DOI":"10.1080\/2162402X.2022.2141973"},{"issue":"1","key":"10749_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathmechdis-051222-115023","volume":"20","author":"A Moyer","year":"2025","unstructured":"Moyer A, Tanaka K, Cheng EH (2025) Apoptosis in Cancer biology and therapy. Annu Rev Pathol 20(1):303\u2013328","journal-title":"Annu Rev Pathol"},{"key":"10749_CR23","unstructured":"Marcela O, Aruna M, Mohamad AH et al (2004) Apoptosis of multiple myeloma. Int J Hematol 80(3)"},{"key":"10749_CR24","doi-asserted-by":"crossref","unstructured":"Fonseca R, Zhu YX, Bruins LA et al (2025) Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention. Blood Cancer J 15(1)","DOI":"10.1038\/s41408-025-01215-x"},{"key":"10749_CR25","doi-asserted-by":"crossref","unstructured":"Lew TE, Seymour JF (2022) Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination. J Hematol Oncol 15(1)","DOI":"10.1186\/s13045-022-01295-3"},{"key":"10749_CR26","first-page":"0","volume":"65","author":"JF-S Dominic","year":"2024","unstructured":"Dominic JF-S, Charlotte H, Matthew M et al (2024) BCL-2 Inhibition in haematological malignancies: clinical application and complications. Blood Rev 65:0","journal-title":"Blood Rev"},{"key":"10749_CR27","doi-asserted-by":"crossref","unstructured":"De Ram\u00f3n C, Rojas EA, Misiewicz-Krzeminska I et al (2024) Expression profile of Bcl\u20102 family proteins in newly diagnosed multiple myeloma patients. HemaSphere 8(12)","DOI":"10.1002\/hem3.70036"},{"key":"10749_CR28","doi-asserted-by":"crossref","unstructured":"Haruya O, Shinsuke M, Taku T et al (2024) Robust anti-myeloma effect of TAS0612, an RSK\/AKT\/S6K inhibitor, with venetoclax regardless of cytogenetic abnormalities. Leukemia 39(1)","DOI":"10.1038\/s41375-024-02439-9"},{"issue":"19","key":"10749_CR29","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1182\/bloodadvances.2020004146","volume":"5","author":"LJ Costa","year":"2021","unstructured":"Costa LJ, Davies FE, Monohan GP et al (2021) Phase 2 study of venetoclax plus Carfilzomib and dexamethasone in patients with relapsed\/refractory multiple myeloma. Blood Adv 5(19):3748\u20133759","journal-title":"Blood Adv"},{"key":"10749_CR30","doi-asserted-by":"crossref","unstructured":"Liang C, Liu X, Yu J et al (2025) Hypericin photoactivation induces triple-negative breast cancer cells pyroptosis by targeting the ROS\/CALR\/Caspase-3\/GSDME pathway. J Adv Res 25:S2090-1232(25)00059-1","DOI":"10.1016\/j.jare.2025.01.042"},{"key":"10749_CR31","doi-asserted-by":"crossref","unstructured":"Wang C, Liang D, Shen X et al (2024) Compound 4a induces paraptosis in liver cancer through Endoplasmic reticulum stress mediated by the calreticulin protein. Br J Pharmacol 1\u201318","DOI":"10.1111\/bph.17385"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10749-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10749-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10749-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:24:21Z","timestamp":1766895861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10749-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10749"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10749-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6507935\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"664"}}